Holen Sie sich die Stockscreener-App
15.99
2.62%
-0.43
Handel nachbörslich:
15.00
-0.99
-6.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$16.42
Offen:
$16.36
24-Stunden-Volumen:
764.62K
Relative Volume:
0.59
Marktkapitalisierung:
$735.74M
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-159.90
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
-10.57%
1M Leistung:
-0.50%
6M Leistung:
+1.20%
1J Leistung:
+17.57%
1-Tages-Spanne:
$15.63
$16.49
1-Wochen-Bereich:
$15.63
$18.04
52-Wochen-Spanne:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
15.99 | 755.53M | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Real time social sentiment graph for Axogen Inc.Stock Surge & Free Safe Entry Trade Signal Reports - newser.com
Why Axogen Inc. is moving today2025 Market Outlook & Reliable Breakout Forecasts - newser.com
How sentiment analysis helps forecast Axogen Inc.Portfolio Update Report & Verified Momentum Watchlists - newser.com
Predicting Axogen Inc. trend using moving averagesWeekly Market Summary & Advanced Technical Analysis Signals - newser.com
Can Axogen Inc. stock weather global recessionJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
AxoGen's (AXGN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Market reaction to Axogen Inc.’s recent newsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc.AXGN - WV News
Axogen, Inc. Experiences Evaluation Revision Amidst Shifting Market Dynamics and Performance Indicators - Markets Mojo
Insider Sell: Burke William P. Mr. Sells Shares of Axogen Inc (A - GuruFocus
William Mr. Burke Sells 736 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
William Mr. Burke Sells 14,571 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $137,236.20 in Stock - MarketBeat
Axogen Director William P. Burke Sells Over 32,000 Shares - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Axogen, Inc. (AXGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Can Axogen Inc. stock continue upward trendGap Down & Free AI Powered Buy and Sell Recommendations - newser.com
How to recover losses in Axogen Inc. stockJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is FDA Review Delay and Legal Scrutiny Altering the Investment Case for Axogen (AXGN)? - Sahm
A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe - Yahoo Finance
AxoGen, Inc. (NASDAQ:AXGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Axogen, Inc. (AXGN) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Axogen Inc.Trend Reversal & Safe Investment Capital Preservation Plans - newser.com
HighMark Wealth Management LLC Has $1.06 Million Position in AxoGen, Inc. $AXGN - MarketBeat
Equities Analysts Issue Forecasts for AxoGen Q3 Earnings - MarketBeat
FDA Extends Review for AxoGen’s Avance Nerve Graft - MSN
Canaccord Genuity reiterates Buy rating on AxoGen stock, citing BLA approval potential - Investing.com
AxoGen (NASDAQ:AXGN) Coverage Initiated at HC Wainwright - Defense World
Canaccord Genuity maintains Buy rating on AxoGen stock amid shutdown concerns - Investing.com Nigeria
Axogen, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – AXGN - MarketScreener
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛
AxoGen (NASDAQ:AXGN) Now Covered by HC Wainwright - MarketBeat
AxoGen stock rating reiterated as Buy by H.C. Wainwright By Investing.com - Investing.com Nigeria
AxoGen stock rating reiterated as Buy by H.C. Wainwright - Investing.com Nigeria
HC Wainwright Initiates Axogen at Buy With $25 Price Target - MarketScreener
AXGN: HC Wainwright & Co. Initiates Coverage With Buy Rating | A - GuruFocus
HC Wainwright & Co. Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq
H.C. Wainwright Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $25 - 富途牛牛
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Burke William P. Mr. | Director |
Oct 03 '25 |
Sale |
18.21 |
14,571 |
265,283 |
2,293 |
| Burke William P. Mr. | Director |
Oct 03 '25 |
Sale |
18.21 |
7,600 |
138,367 |
0 |
| Burke William P. Mr. | Director |
Oct 02 '25 |
Sale |
18.01 |
7,620 |
137,200 |
16,864 |
| Burke William P. Mr. | Director |
Oct 02 '25 |
Sale |
18.01 |
2,400 |
43,224 |
7,600 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):